drugset / Trial / NCT01039740
Pharmacogenetic Study of Mirtazapine Response in Depressed Patients
Non-randomizedSingle-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether pharmacogenetic study predict Mirtazapine responsiveness in advance before the appearance of the drug effect until 4-6 weeks after administration of Mirtazapine.
Timeline
- Start
- 2003-02
- Primary completion
- 2017-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirtazapine | Other / unclassified | — | — |